Collections
@industrydocs on Twitter
Industry Documents RSS Feed
We hope this showcase of how scholars, students, journalists, policymakers, advocates and others are using OIDA resources will inspire future work.
Gaurab Bhardwaj, Associate Professor of Management, Babson College
How do you use OIDA in your teaching, research, or advocacy? The archive and publications based on it have been invaluable for my own learning about the opioid epidemic. It led me to design a decision-making exercise to encourage my students to consider the ethical dimensions of business decisions. Because the role of companies in the opioid epidemic is now well known, I disguise the drug and company names to prevent preconceived ideas and biases. I have them look at clinical data and ask whether they would commercialize the drug and why. Many say yes, some say no. We discuss everyone's reasoning. We go through another decision or two. Then, I reveal that the company is Purdue Pharma and the drug is OxyContin. Without the benefit of hindsight, students develop a better appreciation for how business decisions can be detached from ethical considerations and lead to disastrous consequences later. It is one thing to learn how someone else in the past made unethical decisions and conclude that you would never do it. It is quite sobering to discover that you might make the same decision when driven by corporate goals and omitting the ethical dimensions.
What advice would you give to people new to OIDA? In addition to following the research guidelines and tools available on the website, I have particularly enjoyed the “featured” function on the homepage that showcases documents randomly. The unexpected nature of it appeals to my sense of discovery and serendipity. It makes my own learning fun, and it often leads me to information I would not have known to seek.
We hope this showcase of how scholars, students, journalists, policymakers, advocates and others are using OIDA resources will inspire future work.
Daniel Eisenkraft Klein, Postdoctoral Fellow, Program on Regulation, Therapeutics, And Law, Brigham and Women’s Hospital, Harvard Medical School
How do you use OIDA in your teaching, research, or advocacy? I view the Opioid Industry Documents Archive (OIDA) as an unparalleled resource for understanding how corporate strategies helped to drive the overdose crisis. My team and I used OIDA documents to examine how Mallinckrodt Pharmaceuticals deployed incentive structures, sales contests, and rhetorical strategies as part of “Operation Change Agent,” a campaign to shift prescribers from OxyContin to its own opioid products. I’ve also used OIDA in my teaching to anchor discussions of the commercial determinants of health in real-world documents, helping students to move past theory and see how these strategies play out in practice.
What advice would you give to people new to OIDA?
Don’t assume all the major stories have already been told. We’ve previously written about the many untapped possibilities for future research with the Archive, but those examples are just the tip of the iceberg. For instance, much more attention is needed on how the industry has sought to expand internationally by lobbying for the deregulation of opioids abroad. These types of studies will offer important insights into how industry strategies have contributed to unequal patterns of opioid-related harms around the world.
Also – don’t hesitate to reach out for assistance from the amazing archivists and librarians! They’re incredible partners for this kind of work.
As a Canadian, I view OIDA as a powerful template for what meaningful document disclosure can and should look like in future settlements – including our own – to ensure that corporate accountability is paired with public access to the truth.
We are excited to announce the addition of the Poison Papers, a collection of approximately 4,700 documents gathered primarily by Carol Van Strum during her battles with Dow, Monsanto, the Environmental Protection Agency (EPA), National Forestry Service, and others over PCBs, dioxin, and the aerial spraying of herbicide 2,4,5-T in the Oregon forest where she lived.
The chemical dioxin, a serious pollutant of chemical and pulp and paper manufacturing, was a contaminant in Agent Orange, which the U.S. military sprayed in Vietnam and was linked to serious health problems, including birth defects.
Read the full announcement on the UCSF Program on Reproductive Health and the Environment (PRHE) blog.
UCSF PRHE and the Bioscience Resource Project facilitated the donation of this collection and the UCSF Library Access Services Team provided the indexing of the documents. Thank you so much for helping to make these materials available to the public!
We added over 220,000 documents to the Teva and Allergan Documents. This batch brings the collection to more than 1.9 million documents and includes training materials, marketing communications, and more. With this batch, OIDA reached the 5 million documents milestone!
The Teva and Allergan collection will encompass about 2 million documents when complete. Processed documents are being made public on a rolling basis with monthly releases expected through 2025.
This month, IDL staff added over 189,000 documents produced by the Settling States in the multistate litigation against Juul Labs. When complete, the Juul Labs collection will contain approximately 7 million documents. IDL is working through the files as quickly as possible and will post new documents every month.
North Carolina Juul Labs Collection
5,940 new files have been added to the Juul Labs Collection under the State of North Carolina sub-collection. These materials represent the final batches to be processed from the North Carolina settlement agreement.
Included in this final batch of documents are 480 ZIP files that were previously an archival processing challenge due to the loss of the original compressed file structure during the e-discovery process. The IDL team was wrangling with approximately 300,000 discrete records that did not make sense without the greater context of their original ZIP wrapper and sibling records. We reconstructed these original files, collapsing 300,000 documents into 480 ZIP files. We hope this work increases context and research value to these groups of files as these records often contain marketing designs or scientific product testing data.
UNC Libraries has created a comprehensive research guide to help you navigate the Juul Labs documents from the North Carolina settlement. This guide provides insight into the origins of the Juul Collection, covering the history of Juul Labs, the NC litigation, and key themes found in the documents. Whether you're researching industry practices, public health impacts, or legal actions, this resource is full of information to get you started.
Join us for our second annual Opioid Industry Documents Archive National Symposium, to be held online May 6 - May 8, noon-2:30 pm (ET) / 9-11:30 am (PT).
For details on speakers and to register, visit: https://oida-resources.jhu.edu/oida-events/oida-national-symposium-2025/.
Introducing a new series in our blog and emails, OIDA Researchers Share! We hope this showcase of how scholars, students, journalists, policymakers, advocates and others are using OIDA resources will inspire future work.
Maud Bernisson, postdoctoral fellow at LISIS (Laboratoire Interdisciplinaire Sciences Innovations Sociétés), CNRS (Centre national de la recherche scientifique), Université Gustave Eiffel (Paris, France)
How do you use OIDA in your teaching, research, or advocacy? In terms of research, I find the OIDA an invaluable resource. The diversity and massive amount of documents in the OIDA have been particularly helpful for me to develop different approaches to examine publication planning in detail. For example, with colleagues, we have found documents like contracts and publications to study how a pharmaceutical company like Mallinckrodt implement publication planning. The OIDA has also helped me to identify types of documents needed for publication planning, like publication guidelines, that I could then gather from other sources as well to further study the ethics of publication planning. The OIDA is thus an essential resource to research this topic.
What advice would you give to people new to OIDA? In my experience, using serendipity to dive into the database helped to learn about the opioid manufacturers, their internal organisation and communications. It also helped find unexpected information, like contracts or drafts of publications. Serendipity is however not always a viable option since it requires time. For users who cannot afford it, I would advise them to start by reading the documentation provided by the OIDA and learn about the role of these companies in the opioid crisis, and what has already been documented thanks to this database. The advantages of the OIDA are not only the massive amount of data and the available documentation but also its structure and the search criteria available. The database indeed permits users to explore the bowels of several companies, which includes its internal organisation, communications, and work topics. This information provides a context essential to then focus on a specific inquiry.
The Opioid Industry Documents Archive (OIDA) is hosting a national symposium, Tuesday, May 6 through Thursday, May 8, noon-2:30 PM (ET) / 9:00 AM-11:30 AM (PT). This unique virtual symposium offers a series of complementary panels that demonstrates OIDA’s value in addressing fundamental questions of importance to historians, health policy and legal experts, journalists, archivists and people with lived experience.
Dates: Tuesday, May 6 through Thursday, May 8 – each day noon to 2:30 PM ET (9:00 AM-11:30 AM PT)
Day 1: Health Journalism, Law and Policy (Tuesday, May 6) This group of experts will discuss the role of journalism and storytelling in the development of laws and policies designed to prevent further harms from the opioid crisis, and the critical role of document disclosure as a means to improve public health.
Day 2: Information Science (Wednesday, May 7) In the digital age, organizational records are being produced on a scale that dwarfs earlier archives of institutional records. Speakers will talk about the challenges and opportunities of managing and providing access to massive digital collections like OIDA.
Day 3: Histories and Stories of the Opioid Crisis (Thursday, May 8) This interdisciplinary panel will explore the ways in which OIDA collections serve as an important resource for looking back and looking forward, telling new stories and developing new analyses about the worst drug epidemic in U.S. history.
For more details on speakers and how to register, please visit https://oida-resources.jhu.edu/oida-national-symposium-2025/.
OIDA staff added over 220,000 documents to the Teva and Allergan Documents. This batch brings the collection to more than 1.7 million documents and includes training materials, marketing communications, and more.
The Teva and Allergan collection will encompass about 1.9 million documents when complete. Processed documents are being made public on a rolling basis with monthly releases expected through 2025.
This month, IDL staff added over 200,000 documents produced by the Settling States in the multistate litigation against Juul Labs. When complete, the Juul Labs collection will contain approximately 7 million documents. IDL is working through the files as quickly as possible and will post new documents every month.
North Carolina Juul Labs Collection18,000 new files have been added to the Juul Labs Collection under the State of North Carolina sub-collection. These materials represent some of the final batches to be processed from the North Carolina settlement agreement.
Explore the new NC Juul Labs Research Guide!
UNC Libraries has created a comprehensive research guide to help you navigate the Juul Labs documents from the North Carolina settlement. This guide provides insight into the origins of the Juul Collection, covering the history of Juul Labs, the NC litigation, and key themes found in the documents. Whether you're researching industry practices, public health impacts, or legal actions, this resource is full of information to get you started.
A team at the Climate Litigation Lab at the University of Oxford Sustainable Law Programme has built a free AI research assistant using our fossil fuel industry documents! The Climate Accountability Research Assistant (CLARA) uses large language models and the latest techniques in information retrieval to interrogate large collections of litigation-relevant historical documents, opening new possibilities for research.
Read more about it in this LinkedIn post.
Please follow us @ucsf-industrydocs.bsky.social for updates about new documents and events. We also continue to post to LinkedIn, Mastodon, and Twitter/X to stay connected with our research community wherever they are.
We’re busy updating our IDL website, which will launch later this year with a more modern design, faster performance, and better compatibility with mobile devices. As part of this work, we’re collecting feedback from people who use our website.
If you’re interested in taking part in this user research, please email us at industrydocuments@ucsf.edu. Your feedback will be invaluable in helping us make our website easy to navigate for all our users.
Introducing a new series in our blog and emails, OIDA Researchers Share! We hope this showcase of how scholars, students, journalists, policymakers, advocates and others are using OIDA resources will inspire future work.
Dorie Apollonio, Professor in the Department of Clinical Pharmacy at the University of California, San Francisco
How do you use OIDA in your teaching, research, or advocacy? I’ve been working with the Opioid Industry Documents Archive since its inception (technically even before that, when the first 503 documents were still held in the Drug Industry Documents Archive). Most of my involvement is a combination of teaching and research; two PharmD students I was advising on their capstone research project used those 503 documents to write the first peer-reviewed articles based on OIDA. Since then, I’ve worked with multiple PharmD student groups who’ve written capstone research projects using OIDA, on topics including industry marketing of opioids by using key opinion leaders, opioid marketing strategies that targeted veterans and children, pharmacies’ opioid dispensing practices, and more. Most recently, my team was awarded a five-year grant by the National Institutes of Health (R01DA058687) that relies on OIDA to assess how best to regulate addictive medications.
What advice would you give to people new to OIDA? I’ve learned from working with students that working with industry documents is not intuitive for most people. It’s easier to understand how to use them by attending one of the annual workshops run by the UCSF library, reading the materials on the “New to the Archive?” tab, and possibly meeting with someone who has more experience to get help.
Ravi Gupta, Assistant Professor of Medicine at the Johns Hopkins University School of Medicine
How do you use OIDA in your teaching, research, or advocacy? I am a physician and health policy researcher interested in examining how private entities influence public health, with a particular focus on addiction, including the opioid crisis. Over the past few years, I have been a frequent user of OIDA for both research and teaching. My research has involved in-depth exploration of OIDA to analyze how the opioid industry misused science to promote the safety and effectiveness of prescription opioids. In ongoing work, I am leveraging these materials to investigate the roles of key stakeholders – such as key opinion leaders and medical science liaisons – in shaping the opioid epidemic. Additionally, I have incorporated specific documents into lectures for medical students, using them to illustrate how physicians themselves may be targeted by industry efforts to influence prescribing or promotion of certain therapeutics.
What advice would you give to people new to OIDA? OIDA is an invaluable resource for understanding industry’s role in shaping the opioid crisis. Whether using it for research, journalism, teaching, advocacy, or other purposes, it is essential to become familiar with the archives. A variety of curated documents are available to help users navigate the different collections and apply tools for mining information effectively in OIDA. For those new to OIDA, I recommend taking time to explore the available orientation materials and experimenting with different search strategies. Starting with broad searches can help develop a sense of the available documents, but eventually, narrowing the focus by using specific keywords, filtering by date, or exploring particular industry actors can yield more meaningful insights. Engaging with others who have experience using OIDA—whether through workshops, forums, or colleagues—can also provide valuable guidance on making the most of this rich and ever-evolving resource. Ultimately, OIDA is a dynamic and ever-evolving collection of critical industry documents, making it a powerful tool for deepening our understanding of the opioid crisis.
